Turbox Antithrombin III
by Unipath, Ltd. 510(k)
Active
510(k) K884144
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK884144 | Date20 Dec 1988 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Recalls
No FDA recalls on record, checked 6 Oct 2026.
Specification
- 510(k) Number
- FDA Product Code
- JBQ
- FDA applicant
- Unipath , Ltd.
- Device Class
- Class II
- Regulation
- 21 CFR Part 864.7060
- Advisory Committee
- Hematology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 24 Sep 2026
The Turbox Antithrombin III is a medical device intended for the quantitation of antithrombin III. It is classified under the hematology medical specialty for clinical laboratory use.
This device is regulated under FDA 510(k) number K884144 and is identified by product code JBQ. It is manufactured by Unipath, Ltd. and adheres to regulation number 864.7060.
Other devices from Unipath, Ltd.
Questions
AI-generated answers, 24 Sep 2026
What is the primary clinical use of the Turbox Antithrombin III?
This device is intended for the quantitation of antithrombin III. It is categorized under the hematology medical specialty and is designed specifically for use within clinical laboratory environments to support diagnostic testing.
How is the Turbox Antithrombin III regulated?
The device is regulated under FDA 510(k) number K884144 and adheres to regulation number 864.7060. It is identified by product code JBQ and was determined to be substantially equivalent through the traditional 510(k) submission process.
Who is the manufacturer of this device?
The Turbox Antithrombin III is manufactured by Unipath, Ltd., located in Bedford, United Kingdom. The company manages the production and regulatory compliance for this specific hematology testing device.